Scienture Holdings, Inc. (Nasdaq: SCNX) announced a securities purchase agreement with institutional investors.
The offering consists of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds are expected to be approximately $3.9 million before expenses.
Offering Details
3,225,000 shares at $1.20 per share for gross proceeds of $3.9 million.
Placement Agent
Maxim Group LLC is the sole placement agent for the offering.
Registration Statement
The offering is made under an effective shelf registration statement on Form S-3 (File No. 333-289198).
- The offering will provide Scienture Holdings with additional capital for its pharmaceutical operations.
- This direct offering shows a strong investor interest in Scienture's specialty pharmaceutical products.
The successful completion of this offering indicates market confidence in Scienture Holdings, Inc. as it continues to develop and bring novel specialty products to the market.